Search

everythinglearnresearchcommunity

for

Search:↓

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Blocking autophagy increases survival of inner ear hair cells exposed to gentamicin.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Provenge extends prostate cancer survival by about 4 months.

Zinc improves skin flap survival in rats.

Finasteride harms invertebrates' survival and burial ability.

Lamins are vital for cell survival, organ development, and preventing premature aging.

Copper supplements during pregnancy improve survival and development in mutant mice.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

The new platinum complexes effectively increased survival in rats with tumors, despite some reversible side effects.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Integumentary organs adapt and evolve for survival, with potential uses in regenerative medicine.

Inhibiting HSP90 increases cell adaptability and survival under stress.

High S100B protein levels indicate poor survival in advanced melanoma.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Minoxidil improved rat skin flap survival but was less effective than surgical methods.

Hair follicle pores help cell survival and growth, even after radiation.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Nanofat injections may improve hair graft survival in scarred areas.